Quality of life among polish Fabry patients — a cross-sectional study quality of life among polish Fabry patients

by Żuraw Wioletta, Golicki Dominik, Jurecka Agnieszka, Tylki-Szymańska Anna
Published 2011-12-01

Musculoskeletal manifestations of mucopolysaccharidosis type VI and effects of enzyme replacement therapy

by Marucha Jolanta, Jurecka Agnieszka, Różdżyńska-Świątkowska Agnieszka, Tylki-Szymańska Anna
Published 2012-04-01

Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study

by Jakóbkiewicz-Banecka Joanna, Piotrowska Ewa, Czartoryska Barbara, Tylki-Szymańska Anna, Liberek Anna, Kurlenda Julianna, Węgrzyn Grzegorz, Węgrzyn Alicja
Published 2005-05-01

Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure

by de Ru Minke H, Teunissen Quirine GA, van der Lee Johanna H, Beck Michael, Bodamer Olaf A, Clarke Lorne A, Hollak Carla E, Lin Shuan-Pei, Rojas Maria-Verónica, Pastores Gregory M, Raiman Julian A, Scarpa Maurizio, Treacy Eileen P, Tylki-Szymanska Anna, Wraith J Edmond, Zeman Jiri, Wijburg Frits A
Published 2012-04-01

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease

by Scarpa Maurizio, Almássy Zsuzsanna, Beck Michael, Bodamer Olaf, Bruce Iain A, De Meirleir Linda, Guffon Nathalie, Guillén-Navarro Encarna, Hensman Pauline, Jones Simon, Kamin Wolfgang, Kampmann Christoph, Lampe Christina, Lavery Christine A, Leão Teles Elisa, Link Bianca, Lund Allan M, Malm Gunilla, Pitz Susanne, Rothera Michael, Stewart Catherine, Tylki-Szymańska Anna, van der Ploeg Ans, Walker Robert, Zeman Jiri, Wraith James E
Published 2011-11-01